Pediatric Status Epilepticus: Treat Early and Avoid Delays

Lindsey A Morgan1,2, Jennifer B Hrachovec3, Howard P Goodkin4

  • 1Division of Pediatric Neurology, Department of Neurology, University of Washington, 4800 Sand Point Way NE, Neurology, MB.7.420, Seattle, WA, 98105, USA. Lindsey.morgan@seattlechildrens.org.

Paediatric Drugs
|May 13, 2023
PubMed

Insights

Rapid treatment of pediatric convulsive status epilepticus (cSE) is crucial. Delays in recognition and treatment, especially with first-line benzodiazepines (BZD), worsen outcomes for this neurologic emergency.

Area of Science:

  • Neurology
  • Pediatric Emergency Medicine

Background:

  • Pediatric convulsive status epilepticus (cSE) is a critical neurologic emergency associated with significant morbidity and mortality.
  • Prompt seizure control is essential for preventing long-term complications and improving patient outcomes.

Purpose of the Study:

  • To provide an evidence-based, clinically focused review of pediatric cSE definitions and treatments.
  • To highlight the importance of timely first-line and escalation therapies for cSE management.

Main Methods:

  • Review of existing evidence and clinical guidelines for pediatric cSE treatment.
  • Analysis of factors contributing to treatment delays and barriers in both out-of-hospital and in-hospital settings.

Main Results:

  • Guidelines recommend early treatment, but delays in recognition, benzodiazepine (BZD) administration, and emergency personnel arrival hinder out-of-hospital seizure cessation.
  • In-hospital treatment is also affected by delays in initiating first- and second-line therapies and resource availability.

Conclusions:

  • Timely administration of first-line benzodiazepines followed by prompt escalation to second-line antiseizure medications is critical for established SE.
  • Addressing logistical challenges and improving care pathways can enhance the initial treatment of pediatric cSE.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
232
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
40
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
460
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
709
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
173
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
266